Literature DB >> 12149665

Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients.

Z Tonbul1, L Altintepe, C Sözlü, M Yeksan, A Yildiz, S Türk.   

Abstract

The aim of this study was to compare the results of the 44-h ambulatory blood pressure monitoring (ABPM) data between haemodialysis (HDp) and CAPD patients and to investigate the relation of circadian rhythm in blood pressure (BP) with development of left ventricular hypertrophy. Twenty-two HDp (11 male, 11 female, mean age: 50 +/- 17 years) and 24 CAPDp (11 male, 13 female, mean age: 47 +/- 15 years) were included. Echocardiographic measurements and ABPM were performed in all study groups. ABPM of the first and second days were analysed separately and compared with CAPDp. Left ventricular hypertrophy was detected in 17 of the 22 HDp (77%) and 17 of the 24 CAPDp (71%). There was no significant differences between HD and CAPDp in respect to 44-h, daytime and night-time systolic and diastolic BP values. Although the course of BP in CAPDp was stable during the 44-h period, systolic and diastolic BP levels on the second day were significantly higher than those of on the first day in HDp (P < 0.001 for both). Daytime systolic and diastolic BP levels on the first day in HD group were recorded lower than those of the CAPD group. On the second day, night-time BP readings (both systolic and diastolic BP) were measured significantly higher in the HD group compared with the CAPD group. Twenty-one of the 24 (88%) CAPD patients were dippers, whereas only four of the 22 (18%) HDp were dippers (P < 0.001). Dipper patients had significantly lower left ventricular mass index (LVMI) than non-dipper patients (131 +/- 29 g/m(2) vs 153 +/- 40 g/m(2), P = 0.03). In 44-h ABPM, there were no differences in daytime and night-time systolic and diastolic blood pressures between HD and CAPD patients. Non-dipper patients had increased LVMI as compared with dipper patients. Abnormalities in circadian rhythm of the blood pressure might be one of the implicated factors for development of left ventricular hypertrophy.

Entities:  

Mesh:

Year:  2002        PMID: 12149665     DOI: 10.1038/sj.jhh.1001449

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  10 in total

1.  44-h ambulatory blood pressure monitoring: revealing the true burden of hypertension in pediatric hemodialysis patients.

Authors:  Orly Haskin; Cynthia J Wong; Lonisa McCabe; Brandy Begin; Scott M Sutherland; Abanti Chaudhuri
Journal:  Pediatr Nephrol       Date:  2014-09-26       Impact factor: 3.714

2.  Night-time blood pressure and pulse wave velocity in dialysis patients.

Authors:  Xiurong Li; Qingbo Jiang; Wenhui Wu; Xianlin Xu; Liying Miao; Lina Jin; Lina Xue; Tian Huang; Jia Di; Jinfeng Liu; Xiaozhou He
Journal:  Clin Exp Nephrol       Date:  2017-08-08       Impact factor: 2.801

3.  Cardiac, Inflammatory and Metabolic Parameters: Hemodialysis versus Peritoneal Dialysis.

Authors:  Silvia Lai; Alessio Molfino; Gaspare Elios Russo; Massimo Testorio; Alessandro Galani; Georgie Innico; Nicla Frassetti; Valentina Pistolesi; Santo Morabito; Filippo Rossi Fanelli
Journal:  Cardiorenal Med       Date:  2014-12-13       Impact factor: 2.041

4.  Blood pressure measurement in peritoneal dialysis: which method is best?

Authors:  Michelle M O'Shaughnessy; Martin Durcan; Sinead M Kinsella; Matthew D Griffin; Donal N Reddan; David W Lappin
Journal:  Perit Dial Int       Date:  2013-04-01       Impact factor: 1.756

5.  Prognostic values of left ventricular mass index progression in incident peritoneal dialysis patients : a prospective cohort study.

Authors:  Yun Chen; Shuqi Dai; Xiaolin Ge; Da Shang; Qionghong Xie; Chuanming Hao; Tongying Zhu
Journal:  BMC Nephrol       Date:  2022-05-31       Impact factor: 2.585

6.  Pharmacokinetics and antihypertensive effects of candesartan cilexetil in patients undergoing haemodialysis: an open-label, single-centre study.

Authors:  Egbert Godehard Schulz; Shadfar Bahri; Volker Schettler; Aron-Frederik Popov; Matthias Hermann
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 7.  Assessment and Management of Hypertension among Patients on Peritoneal Dialysis.

Authors:  Vasilios Vaios; Panagiotis I Georgianos; Vassilios Liakopoulos; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-19       Impact factor: 8.237

Review 8.  Assessment and management of hypertension in patients on dialysis.

Authors:  Rajiv Agarwal; Joseph Flynn; Velvie Pogue; Mahboob Rahman; Efrain Reisin; Matthew R Weir
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

9.  Factors associated with systolic hypertension in peritoneal dialysis patients.

Authors:  Surachet Vongsanim; Andrew Davenport
Journal:  J Nephrol       Date:  2019-08-10       Impact factor: 3.902

10.  Blood pressure profile in continuous ambulatory peritoneal dialysis patients.

Authors:  Rizna Abdul Cader; Halim Abdul Gafor; Rozita Mohd; Suriani Ibrahim; W H Wan Haslina; Arba'iyah Bain; Norella Ct Kong
Journal:  EXCLI J       Date:  2012-03-28       Impact factor: 4.068

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.